桦褐孔菌粗多糖对胰岛素抵抗糖脂代谢紊乱大鼠的改善作用OA
Crude Polysaccharides from Inonotus obliquus Ameliorate Insulin Resistance and Glucose-Lipid Metabolism Disorders in Rats
为探讨桦褐孔菌(Inonotus obliquus)粗多糖(C-IOPS)对胰岛素抵抗糖脂代谢紊乱大鼠的改善作用,采用高脂饮食联合四氧嘧啶构建胰岛素抵抗糖脂代谢紊乱大鼠模型,大鼠适应性饲养5 d,随机分为空白对照组、模型组、阳性对照组(二甲双胍107 mg·kg-1),以及桦褐孔菌粗多糖低(100 mg·kg-1)、中(200 mg·kg-1)、高(400 mg·kg-1)剂量组,每组10只,分别测定血糖、血清指标、肝脏组织炎症因子含量,通过组织切片观察细胞形态、组织结构和病理特征,采用蛋白质免疫印迹法测定肝脏组织中蛋白激酶B(protein kinase B,AKT)、磷酸化蛋白激酶 B(phosphorylated protein kinase B,p-AKT)、糖原合成酶激酶-3β(glycogen synthase kinase-3β,GSK-3β)和磷酸化糖原合成酶激酶-3β(phosphorylated glycogen synthase kinase-3β,p-GSK-3β)的表达量,并计算p-AKT/AKT和p-GSK-3β/GSK-3β蛋白质表达量的比值.结果表明:与模型组相比,阳性对照组和桦褐孔菌粗多糖各剂量组第33天体质量、p-AKT/AKT和p-GSK-3β/GSK-3β的比值显著增加,空腹血糖、0.5 h血糖、曲线下面积,以及甘油三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)、低密度脂蛋白(low-density lipoprotein cholesterol,LDL-C)、白细胞介素-1β(interleukin-iβ,IL-iβ)、白细胞介素-6(interleukin-6,IL-6)和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)含量显著降低,阳性对照组和桦褐孔菌粗多糖高剂量组2 h血糖、丙氨酸氨基转移酶(alanine aminotransferase,ALT)活性显著降低,阳性对照组和桦褐孔菌粗多糖中、高剂量组天门冬氨酸氨基转移酶(aspartate aminotransferase,AST)活性显著降低,桦褐孔菌粗多糖可减少肝细胞水肿和肝脏组织脂肪变性,其作用机制可能与AKT和GSK-3β信号通路有关.桦褐孔菌粗多糖可以改善胰岛素抵抗糖脂代谢紊乱.
The medicinal mushroom Inonotus obliquus has long been used in traditional medicine for metabolic disorders;however,the therapeutic potential of its crude polysaccharides(C-IOPS)against insulin resistance and glucose-lipid metabolic disturbances remains unexplored.To study the ameliorative effects of C-IOPS in insulin resistant rats with glucose and lipid metabolism disorder,an insulin resistant rat model was established using a high-fat diet combined with alloxan induction.After 5 days of adaptive feeding,the rats were randomly divided into six groups(n=10 per group):blank control group,model group,positive control group(metformin,107 mg·kg-1·d-1),and three C-IOPS-treated groups at low(100 mg·kg-1·d-1),medium(200 mg·kg-1·d-1),and high(400 mg·kg-1·d-1)doses.Rats in the blank control group received no gavage,while those of the model group were administered 2.5 mL distilled water by gavage.The positive control group received 2.5 mL metformin hydrochloride solution at a dose of 107 mg·kg-1,and the low-,medium-,and high-dose C-IOPS groups were administered 2.5 mL C-IOPS solution at doses of 100,200,and 400 mg·kg-1,respectively,by gavage once daily.Blood glucose,serum parameters,and hepatic inflammatory cytokines were measured.Liver tissue morphology,structure,and pathological features were examined by histology.Protein expression levels of protein kinase B(AKT),phosphorylated AKT(p-AKT),glycogen synthase kinase-3β(GSK-3β),and phosphorylated GSK-3β(p-GSK-3β)in liver tissue were determined by Western blotting,and the ratios of p-AKT/AKT and p-GSK-3β/GSK-3β were calculated.The results showed that after three days of intervention,compared with the model group,the positive control group and all C-IOPS groups exhibited significant increased body weight,and elevated hepatic p-AKT/AKT and p-GSK-3β/GSK-3β ratios.Fasting blood glucose,0.5-h postprandial glucose,the area under the glucose curve,triglyceride(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),and hepatic proinflammatory cytokines including interleukin-iβ(IL-1β),IL-6,and tumor necrosis factor-α(TNF-α)were significantly decreased.Compared with the model group,the positive control group and high-dose C-IOPS group showed significantly reduced 2-h blood glucose and alanine aminotransferase(ALT)activity,while the positive control group and medium-and high-dose C-IOPS groups exhibited significantly decreased aspartate aminotransferase(AST)activity.Histopathological analysis showed that C-IOPS attenuated hepatocellular edema and hepatic steatosis.These findings suggest that the beneficial effects of C-IOPS are mediated,at least in part,through the AKT and GSK-3β signaling pathways.Our study provides evidence that crude polysaccharides from I.obliquus hold promise as a dietary intervention for ameliorating insulin resistance and glucose-lipid metabolic disorders.
娜迪拉·依米提;刘梦文;白天雅;彭星;段书彦;肖辉;沈静
新疆医科大学公共卫生学院,新疆乌鲁木齐 830017新疆维吾尔自治区临床营养研究所,新疆乌鲁木齐 830001||新疆维吾尔自治区人民医院临床营养科,新疆乌鲁木齐 830001新疆医科大学公共卫生学院,新疆乌鲁木齐 830017新疆医科大学公共卫生学院,新疆乌鲁木齐 830017新疆医科大学公共卫生学院,新疆乌鲁木齐 830017新疆医科大学公共卫生学院,新疆乌鲁木齐 830017新疆医科大学公共卫生学院,新疆乌鲁木齐 830017
桦褐孔菌粗多糖糖脂代谢改善机制
Inonotus obliquuscrude polysaccharideglycolipid metabolismameliorationmechanism
《食用菌学报》 2026 (3)
75-83,9
自治区重点研发计划项目(2024B02022)
评论